Paterna Biosciences: Funding, Investors & Team (Oct 2026)
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant challenges of male infertility. We recognize the critical gap in male fertility treatment and are committed to helping people on their path to parenthood. Our innovative in-vitro spermatogenesis (IVS) technology is poised to transform the fertility landscape, offering new hope and innovative solutions to those struggling to conceive. Led by a team of world-renowned scientists and physicians, we are advancing research into clinical applications. Our mission is to make parenthood a reality for more families through ethical, scientifically advanced fertility solutions. Did you know? *1 in 8 couples struggle with infertility. *50% of in vitro fertilization (IVF) procedures fail. *50% of infertility is linked to men. *Male infertility treatment has been stagnant since 1992. Paterna is the first to develop a truly new treatment for male infertility since then. With a strong foundation in science and a commitment to innovation, Paterna BioSciences is uniquely positioned to lead the next generation of male fertility treatments. We are actively seeking funding to accelerate our clinical development and commercialization efforts, bringing our life-changing technology to families worldwide. We help make parenthood possible. Learn more at www.PaternaBio.
Paterna Biosciences has raised $12.3M across 2 funding rounds on record, the most recent a Series A of $6.3M announced in Aug 2026.
That round is below the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Paterna Biosciences Company Profile and Key Stats
Latest funding round on record: Aug 2026.
Paterna Biosciences Funding Rounds
Paterna Biosciences raised $6.0M in a Seed announced in Oct 2024.
1.8 years later, a Series A of $6.3M was announced in Aug 2026.
Paterna Biosciences Investors
6 investors are recorded in total; the 5 named above are those the record identifies.
Paterna Biosciences Founders and Leadership Team
Contact details for the Paterna Biosciences team: 2 of 2 have an email address on file, 2 have a LinkedIn profile.
Start 14-day free trial →Paterna Biosciences Funding Compared to Other Biotechnology Startups
Paterna Biosciences' latest round of $6.3M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Paterna Biosciences in Biotechnology and Salt Lake City
Companies Similar to Paterna Biosciences
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Paterna Biosciences Funding FAQs
What does Paterna Biosciences do?
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant challenges of male infertility. We recognize the critical gap in male fertility treatment and are committed to helping people on their path to parenthood. Our innovative in-vitro spermatogenesis (IVS) technology is poised to transform the fertility landscape, offering new hope and innovative solutions to those struggling to conceive. Led by a team of world-renowned scientists and physicians, we are advancing research into clinical applications. Our mission is to make parenthood a reality for more families through ethical, scientifically advanced fertility solutions. Did you know? *1 in 8 couples struggle with infertility. *50% of in vitro fertilization (IVF) procedures fail. *50% of infertility is linked to men. *Male infertility treatment has been stagnant since 1992. Paterna is the first to develop a truly new treatment for male infertility since then. With a strong foundation in science and a commitment to innovation, Paterna BioSciences is uniquely positioned to lead the next generation of male fertility treatments. We are actively seeking funding to accelerate our clinical development and commercialization efforts, bringing our life-changing technology to families worldwide. We help make parenthood possible. Learn more at www.PaternaBio.
How much funding has Paterna Biosciences raised?
Paterna Biosciences has raised $12.3M across 2 rounds on record. The most recent is a Series A of $6.3M announced in Aug 2026.
When did Paterna Biosciences last raise funding?
Paterna Biosciences' most recent funding round on record is a Series A of $6.3M, announced in Aug 2026.
Who has invested in Paterna Biosciences?
Investors on record for Paterna Biosciences include SpringTide Ventures, Divergent Capital, Seaside Ventures, e184, IVIRMA GLOBAL. FundedIQ records 6 investors in total.
Who founded Paterna Biosciences?
FundedIQ lists Alex Pastuszak (Cofounder, CEO), Ed Rowland (Founder) at Paterna Biosciences.
Where is Paterna Biosciences headquartered?
Paterna Biosciences is based in Salt Lake City, Utah, United States.
How many employees does Paterna Biosciences have?
Paterna Biosciences is in the 11-50 employee band.
When was Paterna Biosciences founded?
Paterna Biosciences was founded in 2020.
How does Paterna Biosciences' funding compare to other Biotechnology startups?
Paterna Biosciences' latest round of $6.3M is below the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Paterna Biosciences Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Paterna Biosciences is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.